Detalles de la búsqueda
1.
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events.
Ann Rheum Dis
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609158
2.
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression.
Ann Rheum Dis
; 83(4): 464-474, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233103
3.
Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment.
Rheumatology (Oxford)
; 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514392
4.
Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapies.
Lupus
; 31(14): 1726-1734, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169280
5.
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus.
Ann Rheum Dis
; 80(6): 758-766, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33568388
6.
Comorbidities Burden and Implementation of the Treat-to-Target Strategy in Predicting Real-World Patient Outcomes in Spondyloarthritides.
Mediterr J Rheumatol
; 34(4): 581-587, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38282943
7.
Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study.
J Clin Med
; 11(15)2022 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35893407
8.
Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316.
J Clin Med
; 12(1)2022 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36615195
9.
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
Front Immunol
; 13: 1074044, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36685524
10.
Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus.
Mediterr J Rheumatol
; 31(1): 87-91, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32411939
Resultados
1 -
10
de 10
1
Próxima >
>>